Clinical Study
The Effects of Vitamin E and Omega-3 PUFAs on Endothelial Function among Adolescents with Metabolic Syndrome
Table 2
The baseline and final values of VEGF in the three study groups.
| | Parameter | Vitamin E group
(n = 30) | Omega-3 group
(n = 26) | Placebo group
(n = 27) | P value |
| | VEGF (baseline), pg/dL | 249.93 ± 206.60 | 211.96 ± 128.34 | 133.67 ± 118.06 | 0.013 | | VEGF (final), pg/dL | 227.05 ± 340.61 | 103.95 ± 77.77 | 102.25 ± 75.52 | 0.073 | | P value | 0.308 | 0.001 | 0.679 | | | VEGF, pg/dL | 32.59 ± 151.04 | 132.79 ± 113.35 | 24.76 ± 105.99 | |
|
|
VEGF: vascular endothelial growth factor.
|
